Receptors for Neurokinins in Peripheral Organs

  • D. Regoli
  • G. Drapeau
  • S. Dion
  • P. D’Orléans-Juste
Conference paper


Discovered in 1931 by von Euler and Gaddum [1], substance P was the first neuropeptide to be described as a “substance, which lowers the arterial blood pressure of atropinized rabbits by peripheral vasodilatation, and also stimulates the tone and rhythm of the rabbit’s isolated intestine....”


Urinary Bladder Neurokinin Receptor Tachykinin Receptor Smooth Muscle Preparation Pharmacological Preparation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Von Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol 72:74–87Google Scholar
  2. 2.
    Gaddum JH, Schild HO (1934) Depressor substances in extracts of intestine. J Physiol 83:1–14PubMedGoogle Scholar
  3. 3.
    Erspamer V, Anastasi A (1962) Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone. Experientia 18:58–59PubMedCrossRefGoogle Scholar
  4. 4.
    Erspamer V, Anastasi A, Bertaccini G, Cei JM (1964) Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus. Experientia 20:489–490CrossRefGoogle Scholar
  5. 5.
    Leeman SE, Carraway RE (1977) The discovery of a sialologic peptide in bovine hypothalamic extracts: its isolation, characterization as substance P, structure and synthesis. In: Von Euler US and Pernow B (eds) Substance P (Nobel Symposium 37) pp. 5–13, Raven Press, New YorkGoogle Scholar
  6. 6.
    Nawa H, Hirose T, Takashima H, Inayama S, Nakanistri S (1983) Nucleotide sequence of cloned cDNAs for two types of bovine brain substance P precursor. Nature 306:32–36PubMedCrossRefGoogle Scholar
  7. 7.
    Kangawa K, Minamino N, Fujuda A, Matsuo H (1983) Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem biophys Res Commun 116:533–540CrossRefGoogle Scholar
  8. 8.
    Jordan CC, Oehme P (eds) (1985) Substance P: metabolism and biological actions. Taylor and Francis, LondonGoogle Scholar
  9. 9.
    Regoli D, D’Orleans-Juste P, Drapeau G, Dion S, Escher E (1985) Pharmacological characterization of substance P antagonists. In: Hakanson R, Sundler F (eds) Tachykinin Antagonists, Elsevier Sci Publ AmsterdamGoogle Scholar
  10. 10.
    Bertaccini G (1976) Active polypeptides of nonmammalian origin. Pharmacol Rev 28: 127–177PubMedGoogle Scholar
  11. 11.
    Lembeck F, Zetler G (1962) Substance P: a polypeptide of possible physiological significance especially within the nervous system. Int Rev Neurobiol 4:159–215CrossRefGoogle Scholar
  12. 12.
    Pernow B (1983) Substance P. Pharmacol Rev 35:85–140Google Scholar
  13. 13.
    Couture R, Regoli D (1982) Mini review. Smooth muscle pharmacology of substance P. Pharmacology 24:1–25PubMedCrossRefGoogle Scholar
  14. 14.
    Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A (1985) A comparison of the effects of substance P and substance K on blood pressure, salivation and urinary bladder moti1ity in urethane anaesthetized rats. Eur J Pharmacol 113:291–294PubMedCrossRefGoogle Scholar
  15. 15.
    Lundberg JM, Saria A, Theodorsson-Norheim E, Brodin E, Hua X, Martling CR, Gamse R, Hökfelt T (1985) Multiple tachykinins in capsaicin-sensitive afferents: occurrence, release and biological effects with special reference to irritation of the airways. In: Häkanson R, Sundler F (eds) Tachykinin Antagonists pp. 159–170, Elsevier Sci Publ AmsterdamGoogle Scholar
  16. 16.
    Maggi CA, Giuliani S, Manzini S, Santicioli P, Meli A (1986) Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors. J Pharmacol exp Ther (in press)Google Scholar
  17. 17.
    Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A (1986) Mini review. Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J. Autonomic Pharmacol (in press)Google Scholar
  18. 18.
    Laufer R, Warmser U, Friedman ZY, Gilon C, Chorev M, Selinger Z (1985) Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin. Proc Nat Acad Sci 82:7444–7488PubMedCrossRefGoogle Scholar
  19. 19.
    Gamse R, Saria A (1985) Potentiation of tachykinin-induced plasma extravasation by calcitonin-gene related peptide. Eur J Pharmacol 114:61–66PubMedCrossRefGoogle Scholar
  20. 20.
    Couture R, Kerouac R (1986) Plasma protein extravasation to mammalian tachykinins in rat skin: influence of anaesthetic agents and acetylcholine antagonist. Brit J Pharmacol (in press)Google Scholar
  21. 21.
    Erspamer V (1981) The tachykinin peptide family. TINS 4:167–269Google Scholar
  22. 22.
    Falconieri Erspamer G, Erspamer V, Piccinelli D (1980) Parallel bioassay of physalaemin and kassinin, a tachykinin dodecapeptide from the skin of the african frog Kassina senegalensis. N S Arch Pharmacol 311 :61–65CrossRefGoogle Scholar
  23. 23.
    Lee CM, Iversen LL, Hanley MR, Sandberg BEB (1982) The possible existence of multiple receptors for substance P. NS Arch Pharmacol 318:281–287CrossRefGoogle Scholar
  24. 24.
    Sandberg BEB, Iversen LL (1982) Substance P. J med Chem 25:1009–1015PubMedCrossRefGoogle Scholar
  25. 25.
    Buck SH, Burcher E, Shults CW, Lovenberg W, O’Donahue TL (1984) Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science 226:987–989PubMedCrossRefGoogle Scholar
  26. 26.
    Torrens Y, Beaujonan JC, G1winski J (1985) Pharmacological characterization of two tachykinin binding sites in the rat cerebral cortex. Neuropeptides 6:59–70PubMedCrossRefGoogle Scholar
  27. 27.
    Cascieri MA, Chicchi GG, Liang T (1985) Demonstration of two distinct tachykinin receptors in rat brain cortex. J biol Chem 260:1501–1507PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1987

Authors and Affiliations

  • D. Regoli
    • 1
  • G. Drapeau
    • 1
  • S. Dion
    • 1
  • P. D’Orléans-Juste
    • 1
  1. 1.Department of Pharmacology, Medical SchoolUniversity of SherbrookeSherbrookeCanada

Personalised recommendations